Irreversible electroporation for the management of pancreatic cancer: Current data and future directions

Pancreatic cancer is currently the seventh leading cause of cancer death (4.5% of all cancer deaths) while 80%-90% of the patients suffer from unresectable disease at the time of diagnosis. Prognosis remains poor, with a mean survival up to 15 mo following systemic chemotherapy. Loco-regional therma...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiliopoulos, Stavros, Reppas, Lazaros, Filippiadis, Dimitrios, Delvecchio, Antonella, Conticchio, Maria, Memeo, Riccardo, Inchingolo, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Opinion Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846938/
https://www.ncbi.nlm.nih.gov/pubmed/36687122
http://dx.doi.org/10.3748/wjg.v29.i2.223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846938/
https://www.ncbi.nlm.nih.gov/pubmed/36687122
http://dx.doi.org/10.3748/wjg.v29.i2.223

Ejemplares similares